Pieters R - Search Results

1

Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia.

te Winkel ML, Pieters R, Hop WC, de Groot-Kruseman HA, Lequin MH, van der Sluis IM, Bökkerink JP, Leeuw JA, Bruin MC, Egeler RM, Veerman AJ, van den Heuvel-Eibrink MM. te Winkel ML, et al. Among authors: pieters r. J Clin Oncol. 2011 Nov 1;29(31):4143-50. doi: 10.1200/JCO.2011.37.3217. Epub 2011 Sep 26. J Clin Oncol. 2011. PMID: 21947829

2

Different types of non-P-glycoprotein mediated multiple drug resistance in children with relapsed acute lymphoblastic leukaemia.

Pieters R, Hongo T, Loonen AH, Huismans DR, Broxterman HJ, Hählen K, Veerman AJ. Pieters R, et al. Br J Cancer. 1992 May;65(5):691-7. doi: 10.1038/bjc.1992.146. Br J Cancer. 1992. PMID: 1350207 Free PMC article.

3

Relation of 5'-nucleotidase and phosphatase activities with immunophenotype, drug resistance and clinical prognosis in childhood leukemia.

Pieters R, Huismans DR, Loonen AH, Peters GJ, Hählen K, van der Does-van den Berg A, van Wering ER, Veerman AJ. Pieters R, et al. Leuk Res. 1992 Sep;16(9):873-80. doi: 10.1016/0145-2126(92)90033-4. Leuk Res. 1992. PMID: 1405718

4

[Growth hormone therapy and leukemia].

Boose AR, Pieters R, Delemarre-van de Waal HA, Veerman AJ. Boose AR, et al. Among authors: pieters r. Tijdschr Kindergeneeskd. 1992 Feb;60(1):1-6. Tijdschr Kindergeneeskd. 1992. PMID: 1557776 Review. Dutch.

5

Value of routine bone marrow examination for detection of bone marrow relapse in children with standard risk acute lymphoblastic leukemia.

Haumann TJ, van Wering ER, van der Does-van den Berg A, Pieters R, Huisjes AJ, Veerman AJ. Haumann TJ, et al. Among authors: pieters r. Pediatr Hematol Oncol. 1992 Jan-Mar;9(1):41-7. doi: 10.3109/08880019209006395. Pediatr Hematol Oncol. 1992. PMID: 1558775

6

Hypoxanthine-guanine phosphoribosyl-transferase in childhood leukemia: relation with immunophenotype, in vitro drug resistance and clinical prognosis.

Pieters R, Huismans DR, Loonen AH, Peters GJ, Hählen K, van der Does-van den Berg A, van Wering ER, Veerman AJ. Pieters R, et al. Int J Cancer. 1992 May 8;51(2):213-7. doi: 10.1002/ijc.2910510208. Int J Cancer. 1992. PMID: 1568789

7

Adenosine deaminase and purine nucleoside phosphorylase in childhood lymphoblastic leukemia: relation with differentiation stage, in vitro drug resistance and clinical prognosis.

Pieters R, Huismans DR, Loonen AH, Peters GJ, Hählen K, van der Does-van den Berg A, van Wering ER, Veerman AJ. Pieters R, et al. Leukemia. 1992 May;6(5):375-80. Leukemia. 1992. PMID: 1593902

8

Differentiation dependent expression of P-glycoprotein in the normal and neoplastic human kidney.

van Kalken CK, van der Valk P, Hadisaputro MM, Pieters R, Broxterman HJ, Kuiper CM, Scheffer GL, Veerman AJ, Meyer CJ, Scheper RJ, et al. van Kalken CK, et al. Among authors: pieters r. Ann Oncol. 1991 Jan;2(1):55-62. doi: 10.1093/oxfordjournals.annonc.a057825. Ann Oncol. 1991. PMID: 1672598 Free article.

9

Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia.

Pieters R, Huismans DR, Loonen AH, Hählen K, van der Does-van den Berg A, van Wering ER, Veerman AJ. Pieters R, et al. Lancet. 1991 Aug 17;338(8764):399-403. doi: 10.1016/0140-6736(91)91029-t. Lancet. 1991. PMID: 1678081

10

In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood.

Kaspers GJ, Pieters R, Van Zantwijk CH, De Laat PA, De Waal FC, Van Wering ER, Veerman AJ. Kaspers GJ, et al. Among authors: pieters r. Br J Cancer. 1991 Sep;64(3):469-74. doi: 10.1038/bjc.1991.333. Br J Cancer. 1991. PMID: 1911186 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

997 results

Search Page